Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2016. 7 of 15 entries say "Materialised", first in FY2024-Q1. Latest entry: 2026-08-14.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MaterialisedAnnual report
「14 August 2025 20,190 shares 10,095 1,101,488 10,095 1,005,172 (Note) Increase due to the issuance of new shares as restricted stock compensation.」
The company issued 20,190 new shares as restricted stock compensation, confirming as an actual result for the fiscal year an event that could lead to dilution of shareholder value. - FY2026-H1MaterialisedAnnual report
「14 August 2025 20,190 shares 10,095 1,101,488 10,095 1,005,172 (Note) Increase due to the issuance of new shares as restricted stock compensation.」
On 14 August 2025, the company issued 20,190 new shares as restricted stock compensation, creating a new event that could lead to dilution of shareholder value. - FY2025MaterialisedAnnual report
「9 August 2024 23,594 shares 譲渡制限付株式報酬としての新株式発行による増加であります。」
The company issued 23,594 new shares as restricted stock compensation, newly disclosing an event that could lead to dilution of shareholder value as an actual result for the fiscal year. - FY2025-H1MaterialisedAnnual report
「9 August 2024 23,594 shares 譲渡制限付株式報酬としての新株式発行による増加であります。」
The company issued 23,594 new shares as restricted stock compensation, newly disclosing an event that could lead to dilution of shareholder value. - FY2024RestatedAnnual report
「The issuance of new shares as restricted stock compensation, with 10 August 2023 as the payment date, increased the total number of issued shares by 22,849.」
The issuance of new shares under the restricted stock compensation plan has been completed, and the plan remains in place with the potential to dilute shareholder value. - FY2024-Q1MaterialisedAnnual report
「The issuance of new shares as restricted stock compensation, with 10 August 2023 as the payment date, increased the number of shares issued by 22,849 as of the filing date.」
The company carried out an issuance of new shares under the restricted stock compensation plan and disclosed 22,849 shares as an event that could lead to dilution of shareholder value. - FY2023RestatedAnnual report
「The Group has introduced a restricted stock compensation plan for directors, excluding outside directors and directors who are Audit and Supervisory Committee members, and executive officers, with the aim of providing long-term incentives and sharing shareholder value.」
The restricted stock compensation plan, which carries the possibility of dilution of shareholder value through the issuance of new shares, remains in place. - FY2022ReframedAnnual report
「The Group has introduced a restricted stock compensation plan for directors other than outside directors and directors who are Audit and Supervisory Committee members, and executive officers, with the aim of providing long-term incentives and sharing shareholder value. If new shares are issued in the future under the restricted stock compensation plan, the value of the Company’s shares could be diluted.」
The focus of the disclosure has shifted from the previous dilution risk associated with the exercise of share acquisition rights to the future issuance of new shares and dilution risk associated with restricted stock compensation. - FY2021-Q3MitigatedAnnual report
「Between 1 January 2021 and 31 January 2021, the exercise of share acquisition rights increased issued shares by 80,000, capital by ¥6 million and capital surplus by ¥6 million.」
The company disclosed the exercise of share acquisition rights for 80,000 shares after the quarter-end, further reducing dilution exposure from the remaining potential shares. - FY2020MitigatedAnnual report
「In addition, share acquisition rights for 80,000 shares were exercised in May 2020.」
In addition to the 160,000 potential shares, equivalent to 1.5% of issued shares, at the fiscal year-end, 80,000 shares were exercised in May 2020 before the filing, further reducing dilution exposure. - FY2019MitigatedAnnual report
「As of 31 March 2019, the number of potential shares represented by share acquisition rights was 160,000, equivalent to 1.5% of the 10,634,000 issued shares as of the same date.」
The proportion of potential shares declined to 1.5% from 3.4% at the end of FY2017, further reducing dilution exposure. - FY2017MitigatedAnnual report
「As of 31 March 2017, the number of potential shares represented by share acquisition rights was 356,000, equivalent to 3.4% of the 10,438,400 issued shares as of the same date.」
The proportion of potential shares declined to 3.4% from 474,400 shares, or 4.6%, in the previous fiscal year. - FY2016First statedAnnual report
「As of 31 March 2016, the number of potential shares represented by share acquisition rights was 474,400, equivalent to 4.6% of the 10,320,000 issued shares as of the same date.」
The company disclosed the exercisability and dilution of stock options for directors and employees.